Global Live Attenuated Vaccines Market - Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Upcoming Report
  • Nov 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Live Attenuated Vaccines Market By Product Type (Bacterial, Viral), Development (Tissue Culture, Embryonated Eggs, Live Animals), Indication (Tuberculosis, Measles, Rotavirus, Yellow Fever, Oral Polio, Others), Route of Administration (Oral, Injectable), End- Users (Hospitals, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Market Analysis: Global Live Attenuated Vaccines Market

Global live attenuated vaccines market is expected to grow at a growing CAGR in the forecast period of 2019-2026. Increase in strategic alliances between the pharmaceuticals companies and high demand of disease specific novel therapies are the key factors that fueling the market growth.

Market Definition: Global Live Attenuated Vaccines Market

Bispecific antibodies are designed to elicit multifaceted biological effects that require simultaneous binding to two different antigen targets with one molecule. It can be employed wide range of therapeutics application including bind multiple targets, to block multiple pathogenic pathways, target tumor heterogeneity, increase specificity, synergistically induce enhanced therapeutic effects and others.

Market Drivers

  • Ongoing clinical trial  conducted by many pharmaceuticals industries is propelling the growth of this market
  • Growing prevalence of infections worldwide is boosting the market growth
  • High demand of disease specific novel treatment can also act as a market driver
  • The competitive scenario of market and strategic collaborations may boost the market position

Market Restraints

  • Limited operating revenue opportunities for research and development of targeted therapies by many pharmaceuticals is acting as a challenging factor for the growth of this market
  • Low healthcare budget in some developing countries is hamper the market growth
  • Scientific and development challenge in production of live attenuated vaccine is also hinders the market growth

Segmentation: Global Live Attenuated Vaccines Market

By Product Type

  • Bacterial
  • Viral

By Development

  • Tissue Culture
  • Embryonated Eggs
  • Live Animals

By Indication

  • Tuberculosis
  • Measles
  • Rotavirus
  • Yellow Fever
  • Oral Polio
  • Others

By Route of Administration

  • Oral
  • Injectable

By End Users

  • Hospitals
  • Specialty Clinics
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Argentina
    • Peru
    • Rest of South America

  • Europe

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Hungary
    • Lithuania
    • Austria
    • Ireland
    • Norway
    • Poland
    • Switzerland
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Vietnam
    • Rest of Asia Pacific

  • Middle East & Africa

    • South Africa
    • UAE
    • Kuwait
    • Israel
    • Egypt
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In May 2019, Sanofi Pasteur Inc a subsidiary of Sanofi received approval from the FDA for Dengvaxia (Dengue Tetravalent Vaccine, Live) for the prevention of dengue disease caused by serotypes 1 – 4 of the virus in individuals 9 through 16 years of age in the United States. The approval of Dengvaxia provides critical medical prevention for patients living in U.S. dengue endemic areas.

Competitive Analysis:

Global live attenuated vaccines market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares global live attenuated vaccines market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

Few of the major competitors currently working in the global live attenuated vaccines market are Sanofi, Emergent BioSolutions Inc, GlaxoSmithKline plc, Daiichi Sankyo Company, Limited, AstraZeneca, Biological E, SutroVax Inc, Polymun Scientific, Boehringer Ingelheim International GmbH, Merck & Co., Inc, Sanaria and others.

Research Methodology: Global Live Attenuated Vaccines Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global live attenuated vaccines market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions